CIK 0001644963
- Non-accelerated filer
- Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474113275
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- 4 Open-market sale Chief Financial Officer sold 3,840 shares at $12.13 ($46,579)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 3,389 shares at an average $7.96 ($26,982)
- 4 Open-market buy Director bought 2,561 shares at an average $8.23 ($21,086)
- 4 Open-market buy Chief Financial Officer bought 1,200 shares at $9.09 ($10,908)
- 4 Open-market buy Director bought 10,000 shares at $9.31 ($93,100)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 16,000 shares at $6.27 ($100,320)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 4,688 shares at an average $5.59 ($26,204)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at an average $5.86 ($29,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at $4.52 ($4,520)
Page 3 of 5 · 96 filings